On April 14, Guilin Layn Natural Ingredients Corp(002166) ( Guilin Layn Natural Ingredients Corp(002166) ) released the annual report of 2021. In 2021, the company achieved an operating revenue of 1.053 billion yuan, a year-on-year increase of 34.40%; The net profit was 118 million yuan, a year-on-year increase of 37.74%.
Guilin Layn Natural Ingredients Corp(002166) is the first listed company in China’s plant extraction industry and the only national specialized and new small giant enterprise in China’s plant extraction industry. At present, Guilin Layn Natural Ingredients Corp(002166) has three production bases, four marketing centers and five R & D centers in the world. The plant extraction plant where the headquarters is located is a leading large-scale digital intelligent integrated plant in the industry. The American industrial marijuana plant has been listed as a demonstration project in the field of American industrial marijuana extraction by the Indiana government.
In 2021, Guilin Layn Natural Ingredients Corp(002166) plant extraction business had a good development momentum, and natural sweetener business had a strong development momentum, realizing an operating revenue of 634 million yuan, a year-on-year increase of 54.86%, accounting for 60.15% of the total operating revenue.
As the core variety, natural sweetener has become the main driving force of Guilin Layn Natural Ingredients Corp(002166) performance growth. In terms of overseas sales, the purchase volume of fenmeiyi reached US $60.25 million in 2021, with a year-on-year increase of 71.16%, accounting for 39.70% of the company’s total operating revenue. Since the signing of the contract, the cumulative purchase amount has been US $118 million, and the cumulative progress of contract performance has reached 34.30%, which is basically in line with the expectations of both parties.
In terms of industrial marijuana, the global covid-19 pneumonia epidemic was still spreading in 2021, and personnel exchanges and economic activities were greatly affected. The Guilin Layn Natural Ingredients Corp(002166) industrial marijuana project in the United States is facing huge construction pressure such as personnel entry restrictions, equipment transportation difficulties, local epidemic safety and so on Guilin Layn Natural Ingredients Corp(002166) industrial marijuana extraction plant is currently commissioning relevant equipment and processes, and is expected to be officially mass produced before June 30, 2022. The plant has been listed as a demonstration project in the field of industrial marijuana extraction by the Indiana government of the United States, and it is the largest industrial marijuana CBD extraction plant in the United States. The overall design, construction, equipment and safety of the plant are formulated with reference to the high standards of the industry. It is a leading industrial marijuana extraction plant in the world at present. The formal mass production and operation of the project will lay a foundation for the rapid development of the company’s industrial marijuana business.
In addition, as of the disclosure date of the report, hemprise, a Guilin Layn Natural Ingredients Corp(002166) Sun company, has signed a processing intention agreement with an industrial cannabis product provider in the United States. The company preliminarily estimates that the processing fee of the above intention agreement will reach US $255-5.7 million.
In 2021, Huagao biological, a Guilin Layn Natural Ingredients Corp(002166) holding subsidiary, realized an operating revenue of 188 million yuan, accounting for 17.89% of the company’s total operating revenue. Among them, the tea extraction business showed its good revenue and stable growth rate, realizing an operating revenue of 164 million yuan, accounting for 15.54% of the company’s total operating revenue.
Last year, Guilin Layn Natural Ingredients Corp(002166) continued to increase investment in process technology development, application R & D and technological transformation. In 2021, the cumulative R & D investment was 389781 million yuan, an increase of 62.12% over the same period last year. In order to further enhance the comprehensive competitiveness and product added value of the company’s plant extraction business, Guilin Layn Natural Ingredients Corp(002166) plans to raise 238 million yuan to build Rhine natural health products research institute in 2021, and signed a strategic cooperation framework agreement with Hunan Agricultural University. The completion of the Institute will provide a good platform for the company to further accelerate the basic innovation research of plant extract products, strengthen the functional research, efficacy evaluation, safety evaluation, formula application research of plant extract products, and develop healthy consumer products with independent intellectual property rights.
